contract development
- H
Pharmaceutical IPO Success: Sai Parenteral Raises Funds
Sai Parenteral IPO Fully Subscribed on Final Day Led by Institutional Demand IPO Sees Marginal Oversubscription with Strong Institutional Participation New Delhi, March 27 The initial public offering of Sai Parenteral, a diversified pharmaceutical formulation company, achieved full subscription...- Himanshu
- Thread
- contract development equity shares expansion fundraising global formulations initial public offering injectable products institutional investors investment ipo manufacturing organization nse data oral solid dosage formulations pharmaceutical formulation qib sai parenteral
- Replies: 0
- Forum: IPO
- H
Sai Parenteral Raises Over Rs 122 Cr in Pre-IPO Funding
New Delhi, March 23 Sai Parenteral's Ltd, a diversified pharmaceutical formulation company, raised over Rs 122 crore from anchor investors on Monday, a day before its initial public offering (IPO) opens for subscription.Morgan Stanley Asia (Singapore) Pte Ltd, Kotak Lifesciences Fund, Quant...- Himanshu
- Thread
- anchor investors capital raising contract development equity shares global formulations hyderabad india initial public offering injectable products ipo manufacturing organization new delhi oral solid dosage formulations pharmaceutical formulation sai parenteral
- Replies: 0
- Forum: Business